These things always seem to happen together. The same day that the Court of Justice of the EU published its opinion on a single European patent court, one of the most eagerly awaited decisions in ...

Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA System The 12-month results of the Volt CE ...

Acutus’ Catheter-Based Therapy Platform, AcQBlate Force, Will Integrate Multiple Ablation Modalities Guided by Novel Noncontact Mapping Technology to Treat Complex Atrial Arrhythmias CARLSBAD, Calif., ...

Abbott has reported new data from its prospective, non-randomised Volt CE Mark Study, indicating that individuals treated with pulsed field ablation (PFA) therapy using the Volt PFA System for atrial ...

Abbott Laboratories, a firm that ranks #3 on The Top 100 Medical Device Companies List, might have been late to the pulsed-field ablation party, but don’t count it out. New data presented from the ...

Paris-based SafeHeal has begun a CE mark study for its Colovac device that is designed to be used as a bypass after a rectal resection and prevents the need for an ostomy. The study has enrolled its ...

VIENNA, Austria—The Volt pulsed-field ablation (PFA) system (Abbott) is safe and effective for pulmonary vein isolation in patients with atrial fibrillation (AF), according to results from the VOLT CE ...

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., a developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced initiation of patient ...

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic ...

Fees, revenues and renewals are among the areas in the Max Planck Trade Mark Study that cause unease, according to representatives of brand owners’ associations The associations disagreed on the study ...

PFA therapy works differently from traditional cardiac ablation approaches by delivering high energy electrical pulses to targeted areas of cardiac tissue causing abnormal heart rhythms. Abbott ...